Mahajan Imaging, Neuberg Diagnostics form JV to expand across North India

The partners will build an integrated diagnostics network spanning pathology, radiology, genomics and wellness testing, taking over labs in Noida, Lucknow and Jammu while adding collection, logistics and specialist wellness centres.

— Source publishedMon, 31 Aug, 2026, 16:31 IST·First seen Mon, 31 Aug, 2026, 16:37 IST·Source Mint

What happened

Mahajan Imaging & Labs formed a JV with Neuberg Diagnostics to expand integrated pathology, radiology, genomics and wellness testing across North India, taking

Key facts

  • 7 northern states and Union territories
  • More than 200 accredited laboratories
  • 12-14% projected organized diagnostics revenue growth in 2026-27

Why this matters

This JV demonstrates how complementary imaging and pathology capabilities can be combined to accelerate regional diagnostics expansion through acquired lab infrastructure and a fuller care continuum.

What to watch

  • Number and location of new collection centres, wellness centres and diagnostic hubs.
  • Evidence of common branding, digital booking, unified reports and integrated home-collection operations.
  • Accreditation milestones, turnaround-time performance and specialist hiring.
  • New B2B contracts with hospitals, insurers, employers or government health programs.
  • Further acquisitions, capital commitments or expansion into Punjab, Haryana, Rajasthan, Uttarakhand or Himachal Pradesh.
  • Competitive pricing or expansion responses from national diagnostic chains and regional imaging operators.
  • Integrate acquired or taken-over labs under common quality, IT and reporting standards.
  • Add collection centres and sample-logistics routes in Delhi NCR, Uttar Pradesh, Jammu and nearby tier-2 markets.
  • Cross-sell pathology, imaging, genomics and wellness packages through a unified patient and physician referral network.
  • Pursue hospital, insurer, corporate wellness and clinician partnerships to raise utilization.
  • Evaluate further regional lab acquisitions or franchise partnerships to build density before national competitors respond.

Also reported by